Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Jason Cheng is currently working as a Professor. The author's research interests include Clinical Pathology, Histopathology, Hemato Pathology, Surgical Pathology, Diagnosis. The author is serving as an editorial member and reviewer of several international reputed journals. The author has successfully completed his administrative responsibilities. The author has authorized many research articles/books related to Clinical Pathology, Experimental Pathology.
Dr. Jason Cheng’s research is aimed at understanding epigenetic and genetic controls of both normal and abnormal hematopoiesis, especially, myelopoiesis. Dr. Jason Cheng’s laboratory is currently developing and implementing new technologies for genome-wide profiling of epigenetic biomarkers/signatures and exploring their potential clinical use for assisting diagnosis, prognosis and therapeutic management of myelodysplastic syndrome (MDS), leukemia and other diseases. Another major effort in Dr. Cheng’s laboratory is to elucidate pathogenetic mechanisms underlying epigenetic alterations in MDS, leukemia and bone marrow diseases. Dr. Jason Cheng’s clinical interests include general hematopathology, myelodysplastic syndrome (MDS), myeloproliferative neoplasms, other bone marrow diseases and lymphoid disorders.
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals